J8522 Capecitabine, oral, 50 milligrams
Also known as: Xeloda, Oral capecitabine
Capecitabine administered orally at 50 milligrams per dose; a fluoropyrimidine antimetabolite chemotherapy drug.
In Plain Language
Cancer treatment pill; Chemotherapy medication
Clinical Context
Used for metastatic colorectal cancer, breast cancer, and gastric cancer. Converted to 5-fluorouracil in tissues.
RVU Information
CPT J8522 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J8522?
CPT J8522 (Capecitabine, oral, 50 milligrams) is a J Codes (Drugs) code. Capecitabine administered orally at 50 milligrams per dose; a fluoropyrimidine antimetabolite chemotherapy drug.
How is J8522 administered?
CPT J8522 is administered by a healthcare provider, typically via injection or infusion. Used for metastatic colorectal cancer, breast cancer, and gastric cancer. Converted to 5-fluorouracil in tissues. It is used by Oncology, Internal Medicine, Gastroenterology.
When is CPT J8522 used?
Used for metastatic colorectal cancer, breast cancer, and gastric cancer. Converted to 5-fluorouracil in tissues.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.